Advertisement

Virtus Biotech Clinical Trials ETF BBC

Set alert

Price alert · BBC

All alert types
43.05 USD 0.00 0.00%

At close · Oct 30

43.05 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
42.55 × 700
Ask
43.04 × 300

Day range unavailable

28.73 52-week range 56.18
YTD
+11.64%
1 year
+34.36%
Open
—
Prev close
43.05
Mkt cap
34.44M
Vol
0
Avg vol
23.55K
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
0.00
Beta
0.00
Short ratio
0.00
Dividend
0.00
Ex-div date
50-d avg
27.91
200-d avg
27.48

5m chart

Chart tools
Interval

Chart is warming up

The five-minute interval price history for BBC has not been loaded yet. Try again in a moment.

Virtus Biotech Clinical Trials ETF

Issuer
Virtus
Asset class
Sector Equity
Expense ratio
0.65%
Assets under management
$35.24M
NAV
44.05
Holdings
198
Inception
2014-12-16
Top 10 weight
16.14%

Top holdings

  1. KOD Kodiak Sciences Inc 2.26%
  2. TRAX First Tracks Biotherapeutics Inc 1.98%
  3. XNCR Xencor Inc 1.88%
  4. ABCL AbCellera Biologics Inc 1.82%
  5. REPL Replimune Group Inc 1.54%
  6. AMLX Amylyx Pharmaceuticals Inc 1.54%
  7. SGP SpyGlass Pharma Inc 1.36%
  8. PRME Prime Medicine Inc 1.32%
  9. NRIX Nurix Therapeutics Inc 1.23%
  10. MBX MBX Biosciences Inc 1.22%
  11. VRDN Viridian Therapeutics Inc 1.17%
  12. KYMR Kymera Therapeutics Inc 1.14%
  13. DFTX Definium Therapeutics Inc 1.14%
  14. MANE VeraDermics Inc 1.13%
  15. ZBIO Zenas Biopharma Inc 1.11%
  16. LBRX LB Pharmaceuticals Inc 1.08%
  17. ORKA Oruka Therapeutics Inc 1.08%
  18. VOR Vor BioPharma Inc 1.06%
  19. BHVN Biohaven Ltd 1.06%
  20. FDMT 4D Molecular Therapeutics Inc 1.05%
  21. PVLA Palvella Therapeutics Inc 1.04%
  22. VIR Vir Biotechnology Inc 1.02%
  23. MAZE Maze Therapeutics Inc 1.02%
  24. PCVX Vaxcyte Inc 1.01%
  25. JANX Janux Therapeutics Inc 1.00%

Sector weights

  • Healthcare 100.00%

Country weights

  • United States 90.01%
  • Canada 2.44%
  • United Kingdom 2.25%
  • Netherlands 2.04%
  • Ireland 1.59%
  • Switzerland 1.07%
  • China 0.60%

Updated 2026-11-01

Advertisement